ID

14027

Description

Idarubicin at Different Dosages as Induction Therapy for Newly Diagnosed Acute Myeloid Leukaemia; ODM derived from: https://clinicaltrials.gov/show/NCT02277847

Lien

https://clinicaltrials.gov/show/NCT02277847

Mots-clés

  1. 22/03/2016 22/03/2016 -
Téléchargé le

22 mars 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Acute Myeloid Leukemia NCT02277847

Eligibility Acute Myeloid Leukemia NCT02277847

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
age: 14~60 years old;no gender limit.
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
diagnosis: according to the diagnosis standards of aml( with the exception of m3 ) ( according to 2008 who diagnosis criteria of aml)
Description

AML

Type de données

boolean

Alias
UMLS CUI [1]
C0023467
performance status is not bad with eastern cooperative oncology group (ecog) score
Description

ECOG

Type de données

boolean

Alias
UMLS CUI [1]
C1520224
Written informed consent obtained prior to the initiation of any study related procedures
Description

Informed consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
chronic myelogenous leukemia (cml) in crisis phase.
Description

CML

Type de données

boolean

Alias
UMLS CUI [1]
C0023473
aml transformed from other myeloproliferative diseases.
Description

Myeloproliferative disease

Type de données

boolean

Alias
UMLS CUI [1]
C0027022
Patient is accompanied with other progressing neoplasms.
Description

Neoplasms

Type de données

boolean

Alias
UMLS CUI [1]
C0027651
With severe malfunction of liver, lungs, kidneys or heart: the plasma levels of direct bilirubin, indirect bilirubin, alanine transaminase, aspartate transaminase and serum creatinine all are 2 times higher than normal, cardiac function is above grade ii.
Description

Organ function

Type de données

boolean

Alias
UMLS CUI [1]
C1254358
Infection
Description

Infection

Type de données

boolean

Alias
UMLS CUI [1]
C0009450

Similar models

Eligibility Acute Myeloid Leukemia NCT02277847

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age: 14~60 years old;no gender limit.
boolean
C0001779 (UMLS CUI [1])
AML
Item
diagnosis: according to the diagnosis standards of aml( with the exception of m3 ) ( according to 2008 who diagnosis criteria of aml)
boolean
C0023467 (UMLS CUI [1])
ECOG
Item
performance status is not bad with eastern cooperative oncology group (ecog) score
boolean
C1520224 (UMLS CUI [1])
Informed consent
Item
Written informed consent obtained prior to the initiation of any study related procedures
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
CML
Item
chronic myelogenous leukemia (cml) in crisis phase.
boolean
C0023473 (UMLS CUI [1])
Myeloproliferative disease
Item
aml transformed from other myeloproliferative diseases.
boolean
C0027022 (UMLS CUI [1])
Neoplasms
Item
Patient is accompanied with other progressing neoplasms.
boolean
C0027651 (UMLS CUI [1])
Organ function
Item
With severe malfunction of liver, lungs, kidneys or heart: the plasma levels of direct bilirubin, indirect bilirubin, alanine transaminase, aspartate transaminase and serum creatinine all are 2 times higher than normal, cardiac function is above grade ii.
boolean
C1254358 (UMLS CUI [1])
Infection
Item
Infection
boolean
C0009450 (UMLS CUI [1])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial